References
"Implications of the Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines." Circulation: Journal of the American Heart Association. July 13, 2004. http://www.nhlbi.nih.gov. Accessed July 2004.
Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Education Program. U.S. Department of Health and Human Services. Public Health Service. National Instiutes of Health. NIH Publication No. 91-2732.
American Heart Association Guidelines for Primary Prevention of Atheroscleroic Cardiovascular Disease Beginning in Childhood. Circulation. 2003;107:1562-1566. http://www.circulationaha.org. Accessed September 2004.
de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation. 2002 Oct 22;106(17):2231-7.
"FDA Plans to Evaluate Results of Women's Health Initiative Study for Estrogen-Alone Therapy." U.S. Food and Drug Administration. "FDA Talk Paper." March 2, 2004. http://www.fda.gov. Accessed March 2004.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321-33.
Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 1. Cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:49-57.
Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 2. Non-cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:58-66.
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
"Estrogen Plus Progestin Study Stopped Due to Increased Breast Cancer Risk, Lack of Overall Benefit." National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated July 9, 2002; accessed July 9, 2002.
"Women's Health Initiative," National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated April 2004; accessed Sept. 2004.
ACC/AHA/NHLBI clinical advisory on the use and safety of statins [Consensus document] Richard C. Pasternak, Sidney C. Smith, C.Noel Bairey-Merz, Scott M. Grundy, James I. Cleeman, Claude Lenfant Journal of the American College of Cardiology, 7 August 2002 (Vol. 40, Issue3)
"New Statin Recommended for Treating Familial Hypercholesterolemia" Drug and Market Development (20 July 2001). http://www.pharmalicensing.com. Accessed Oct. 2001.
"High Cholesterol Hinders the Effectiveness of Aspirin in Reducing Heart Disease Risk" A report presented at the 73rd Scientific Sessions of the American Heart Association in New Orleans on Nov. 14, 2000. http://www.umm.edu. Accessed Oct. 2001.
"Myriad Genetics Finds Cholesterol Gene" Pharmalicensing. http://www.pharmalicensing.com. Accessed Oct. 2001.
"Three-minute skin test measures cholesterol levels" American Heart Association News Release. Nov. 14, 2000. http://www.americanheart.org. Accessed Oct. 2001.
"Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults." http://www.nhlbi.nih.gov. Executive Summary. Journal of the American Medical Association, May 16, 2001.
"Coronary Heart Disease Explained." National Cholesterol Education Program. National Heart, Lung and Blood Institute. No publication date. http://www.nhlbisupport.com. Accessed June 2000.
"Cholesterol-Lowering Medicines." National Cholesterol Education Program. National Heart, Lung and Blood Institute. No publication date. http://rover.nhlbi.nih.gov. Accessed Dec. 2003.
"Press release: FDA Approves New Health Claim for Soy Protein and Coronary Heart Disease." U.S. Food and Drug Administration. Oct. 20, 1999. http://www.fda.gov. Accessed June 2000.
"Cholesterol Statistics." American Heart Association. Published 2002. http://www.americanheart.org. Accessed Dec. 2003.
Miller, M. Byington, R. Hunninghake, D. et al. "Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and Canada." Archives of Internal Medicine. Vol. 160. Feb. 14, 2000. 343-347.
Anderson, J. Davidson, M. Blonde, L. et al. "Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia." American Journal of Clinical Nutrition. Vol. 71, No. 6. June 2000. 1433-1438.
"AACE Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Dyslipidemia and Prevention of Atherogenesis" 2002 Amended Version. American Association of Clinical Endocrinologists.http://www.aace.com. Accessed Jan. 2002.
"Cholesterol testing at home: It may be faster, but is it better?" The Harvard Medical School Family Health Guide. April 2003 update. http://www.health.harvard.edu. Accessed Nov. 2003.
"Doctors Divided Over Cholesterol Drugs Study." Healthfinder.gov website, U.S. Department of Health and Human Services. Nov. 13, 2003. http://www.healthfinder.gov. Accessed Dec. 2003.
"FDA Approves New Drug for Lowering Cholesterol" FDA Talk Paper on Crestor (rosuvastatin). Aug. 12, 2003. http://www.fda.gov. Accessed Dec. 2003.
"FDA Approves New Drug for Lowering Cholesterol" FDA Talk Paper on Crestor (rosuvastatin). Aug. 12, 2003. http://www.fda.gov/. Accessed Dec. 2003.
"Medicare Coverage for Cardiovascular Disease Prevention Screening." The American Heart Association. 2005. http://www.americanheart.org/. Accessed January 2006.
| |
|
View References for this Health Topic
|
Create Date: 7/12/02
Date Last Updated: 12/12/06
Review Date: 9/15/06
|
|
